Ear drum holes repaired in minutes with growth factor gel
NCT ID NCT06448039
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether a gel containing fibroblast growth factor 2 (FGF2) can close long-lasting holes in the ear drum. Twenty adults with dry ear drum holes that have persisted for over six months will receive either the FGF2 gel or a saltwater placebo. The gel is applied in the doctor's office, and up to four treatments may be given. The goal is to see if this simple approach can heal the hole and improve hearing.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Fibroblast Growth Factor 2 (FGF2)
- What this could lead to
- If it works, this could provide a simple, in-office treatment to close chronic ear drum holes without surgery.
- What could go wrong
- This is a small early-phase trial with only 20 participants. The treatment may not work better than placebo, and up to four applications are needed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 1/2
Runs two stages together: safety and dose first, then whether the treatment works.
- Participants
-
About 20 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2024
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. 18 years of age and older. 2. Confirmed tympanic membrane perforation for more 6 months or longer. 3. Confirmed dry perforation. 4. Confirmed central perforation. 5. Ability to provide informed consent. Exclusion Criteria: 1. Patient is receiving or has a prior history of radiation treatment. 2. Prior tympanoplasty with failure. 3. Currently use of corticosteroids, immunosuppressive agents, or chemotherapy. 4. Active middle ear infection or inflammation on otoscopic examination
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic tympanic membrane perforation are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts Eye and Ear
Boston, Massachusetts, 02214, United States